Camurus AB (publ) (CAMRF)
OTCMKTS · Delayed Price · Currency is USD
68.85
-2.15 (-3.03%)
At close: Aug 22, 2025
Camurus AB Market Cap
Camurus AB has a market cap or net worth of $4.62 billion as of September 8, 2025. Its market cap has increased by 16.11% in one year.
Market Cap
4.62B
Enterprise Value
4.28B
Revenue
238.35M
Ranking
n/a
PE Ratio
61.19
Stock Price
$68.85
Market Cap Chart
Since December 3, 2015, Camurus AB's market cap has increased from 195.65M to 4.62B, an increase of 2,262.88%. That is a compound annual growth rate of 38.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 4.60B | 52.55% |
| Dec 30, 2024 | 3.01B | 1.60% |
| Dec 29, 2023 | 2.97B | 120.93% |
| Dec 30, 2022 | 1.34B | 46.93% |
| Dec 30, 2021 | 914.06M | -25.91% |
| Dec 30, 2020 | 1.23B | 163.54% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
| Dec 3, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 825.37M |
| Elite Pharmaceuticals | 749.52M |
| Tian'an Technology Group | 705.53M |
| Glass House Brands | 600.85M |
| CytoDyn | 396.74M |
| Northwest Biotherapeutics | 376.41M |
| American Oncology Network | 353.52M |